Richard Kramer, Chief Executive of national disability charity Sense, argues that life’s better when we’re all connected when it comes to hearing loss.
The iDEAL group shares their thoughts on invigorating education for today’s diabetes care professionals.
Dr Alison Cernich, Deputy Director of the NICHD, and Dr Theresa Cruz, Acting Director, National Center for Medical Rehabilitation Research at NICHD, describe technology that helps children with disabilities.
The cardiovascular side effects of night-time train noise is placed under the spotlight here by a group of experts from Gutenberg-University Mainz in Germany and the Danish Cancer Society.
Simone Biscaglia, European Society of Cardiology Member, states the case here for what could be the next (cheap) medical revolution, “reasonable” physical activity for all.
Prof Filippo Graziani, President of the European Federation of Periodontology (EFP), turns the spotlight on periodontitis and answers if gum disease increases the risk of hypertension, heart attack and stroke.
Professor Adrian Wilson, MBBS, BSc (Hons), FRCS, FRCS Tr & Orth Specialist Knee Surgeon (Professor), tells us what we need to know about exciting new regenerative treatments that take centre stage for knees in the world of orthobiologics.
Dr Ian Jackson, Medical Director and Clinical Safety Officer at Refero, shares his thoughts on the reality of the Health Systems Support Framework.
Dr Suresh Kuppuswamy, Industry Principal – Healthcare at Frost & Sullivan, explores the future of medical imaging, focussing on Radiology-as-a-Service.
Marco Marsella, Head of Unit, Directorate-General Communications Network, Content and Technology (DG Connect), European Commission, speaks to OAG about AI and digital transformation in healthcare.
Research has found that as many as one in three Brits display symptoms of Seasonal Affective Disorder (SAD) each year. But what exactly is it, what are the symptoms, and how can we combat it in our workplace?
Brian Jones, Chief Executive at Partnership of East London Co-operatives, shares his thoughts on procurement frameworks in the NHS including the GP Futures Framework.
Emily Y. Chew, M.D., Director of the Division of Epidemiology and Clinical Applications and the Deputy Clinical Director at the National Eye Institute, part of the National Institutes of Health, examines why early detection is crucial to prevent blindness from diabetic retinopathy.
In this article, Paul Bomke and Lena Kuntz discuss counselling centres in Germany, particularly in the Palatinate region.
In this article, Dr Hans-Günter Weeß explains the connection between sleep, mental health and strengthening resilience.
Dame Sally calls time on childhood obesity, writes Tam Fry FRSA, Chairman of the National Obesity Forum.
Here, Dr Christine Wekerle explains her in-depth research into youth resilience, which proposes an innovative tool to help cope with trauma.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, examines dementia as a public health issue in Hong Kong.
Jane Kinghorn, Director at UCL Translational Research Office and Anne Lane, CEO at UCL Business Ltd describe the contributing factors to the success of accelerating biomedical therapeutic translation at UCL and their partner hospitals.
Here, Samuel Clark explains The Kappa Theory of Schizophrenia, focusing on the role of the kappa opioid receptor in treatment.